Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc.DNAEarnings & Financial Report

NYSE · Health Care · Biological Products, (No Diagnostic Substances)

Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It...

Top Holders

Holder% OwnedSharesChangeAs of
ARK12.26%
198.6M
2024-01-29
Reshma Shetty10.50%
188.6M
2024-02-14
Viking Global Investors LP8.30%
3.6M
-0.50pp2024-11-14
Nos. of above persons7.87%
134.4M
-6.72pp2024-07-05
The Vanguard Group6.04%
2.6M
flat2024-11-12
Austin Che5.60%
95.9M
2024-02-14
Jason Kelly5.00%
85.8M
2024-02-14
Thomas F. Knight Jr.4.10%
68.3M
2024-02-14

Insider Transactions

Net 90d: $3.55M · buys $0 / sells $3.55M
Range:
Action:
Role:
InsiderRoleAction
2026-04-17Coen Steven P.See remarksSell (open market)
324
$7.95$2.6K
2026-04-16Coen Steven P.See remarksOption exercise
587
2026-04-16Coen Steven P.See remarksOption exercise
156
2026-04-13Coen Steven P.See remarksSell (open market)
33.2K
$6.41$212.8K
2026-04-10Coen Steven P.See remarksOption exercise
28.4K
2026-04-10Coen Steven P.See remarksOption exercise
45.6K
2026-04-10Shetty Reshma P.See remarksSell (open market)
124.7K
$6.43$802.5K
2026-04-10Barry Canton10% OwnerSell (open market)
124.7K
$6.43$802.5K
2026-04-09Shetty Reshma P.See remarksOption exercise
251.8K
2026-04-09Barry Canton10% OwnerOption exercise
251.8K
110 of 25
Page 1 / 3